Mendota Financial Group LLC Takes $124,000 Position in Teleflex Incorporated (NYSE:TFX)

Mendota Financial Group LLC bought a new position in Teleflex Incorporated (NYSE:TFXFree Report) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 698 shares of the medical technology company’s stock, valued at approximately $124,000.

Several other hedge funds have also bought and sold shares of TFX. Janus Henderson Group PLC lifted its stake in shares of Teleflex by 2.8% in the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock valued at $1,329,704,000 after buying an additional 147,147 shares in the last quarter. State Street Corp boosted its stake in Teleflex by 1.0% during the 3rd quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock valued at $508,757,000 after purchasing an additional 21,291 shares during the last quarter. Geode Capital Management LLC increased its holdings in Teleflex by 0.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company’s stock worth $278,676,000 after purchasing an additional 5,746 shares in the last quarter. Massachusetts Financial Services Co. MA raised its stake in shares of Teleflex by 0.4% in the third quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company’s stock worth $105,749,000 after purchasing an additional 1,884 shares during the last quarter. Finally, Point72 Asset Management L.P. lifted its holdings in shares of Teleflex by 31.2% in the third quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock valued at $100,768,000 after purchasing an additional 96,958 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analyst Ratings Changes

TFX has been the subject of several analyst reports. Royal Bank of Canada lowered their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a report on Friday, November 1st. StockNews.com raised shares of Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Mizuho dropped their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Finally, Truist Financial reduced their price objective on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, Teleflex has an average rating of “Moderate Buy” and a consensus target price of $252.50.

View Our Latest Report on TFX

Teleflex Price Performance

TFX stock opened at $178.84 on Tuesday. The firm has a 50 day moving average of $185.76 and a 200-day moving average of $216.38. The firm has a market capitalization of $8.31 billion, a P/E ratio of 35.55, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. Teleflex Incorporated has a 12 month low of $171.69 and a 12 month high of $256.85. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFXGet Free Report) last posted its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.38 by $0.11. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company had revenue of $764.40 million during the quarter, compared to analyst estimates of $768.68 million. During the same quarter last year, the company earned $3.64 earnings per share. The firm’s quarterly revenue was up 2.4% on a year-over-year basis. As a group, sell-side analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, December 16th. Shareholders of record on Friday, November 15th were given a dividend of $0.34 per share. The ex-dividend date was Friday, November 15th. This represents a $1.36 annualized dividend and a yield of 0.76%. Teleflex’s payout ratio is presently 27.04%.

Teleflex Company Profile

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Further Reading

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFXFree Report).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.